ARP-100,
N-hydroxy-2-((4-phenylphenyl)sulfonylpropan-2-yloxyamino)acetamide,
ARP 100,
704888-90-4,
ARP100,
MMP-2 Inhibitor III,
N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide,
CHEMBL181244,
N-Hydroxy-2-(N-isopropoxy-[1,1'-biphenyl]-4-ylsulfonamido)acetamide,
N-2-(Biphenyl-4-Ylsulfonyl)-N-2-(Isopropyloxy)-Acetohydroxamic Acid,
(2-((Isopropoxy)-(1,1′-biphenyl-4-ylsulfonyl)-amino))-N-hydroxyacetamide,
ARP-100,
GTPL5140,
SCHEMBL2029096,
CTK8F1323,
DTXSID30434718,
HMS3648M12,
ZINC3818628,
0914AC,
BDBM50161331,
MFCD09971105,
AKOS016004871,
NCGC00167796-01,
AJ-45723,
DB-074307,
RT-011319,
FT-0718436,
SR-01000946390,
SR-01000946390-1,
2-[(Biphenyl-4-sulfonyl)-isopropoxy-amino]-N-hydroxy-acetamide,
N-hydroxy-2-[N-(propan-2-yloxy)(4-phenylbenzene)sulfonamido]acetamide,
N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(propan-2-yloxy)glycinamide,
2-[((1,1'-Biphenyl)-4-ylsulfonyl)-(1-methylethoxy)amino]-N-hydroxyacetamide,
D0Q4TA,
C17H20N2O5S,
PHGLPDURIUEELR-UHFFFAOYSA-N,
CB11415,
CID10044321,
A4432,
A15292,
N-hydroxy-2-[(4-phenylphenyl)sulfonyl-propan-2-yloxy-amino]acetamide,
10B,